文献速递细菌感染、耐药与抗菌药物医院感染防控

医护人员肠道多重耐药菌定植研究

Healthcare personnel intestinal colonization with multidrug-resistant organisms.
PubMed 文献 · Clin Microbiol Infect · 2017-05-12

结果显示医护人员定植率4.0%与无接触者3.2%无显著差异,提示非暴发 settings 下医护人员肠道定植对院内传播作用有限。

要点

  • 医护人员肠道多重耐药菌定植率低,与无患者接触者无显著差异
  • 产ESBL菌检出率3.4%,仅检出1株产碳青霉烯酶菌,未检出VRE
  • 非暴发情况下医护人员肠道定植对院内MDRO传播作用有限

核心结论

  • 医护人员肠道MDRO定植率低,可能反映当地社区背景定植率,提示非暴发情况下医护人员肠道定植对院内MDRO传播作用有限。

主要发现

  • 800名参与者中94.4%(755/800)提交至少一次拭子,91.4%(731/800)提交问卷。
  • 产ESBL菌从3.4%(26/755)参与者中检出,仅检出1株产碳青霉烯酶菌,未检出VRE。
  • 报告照护MDRO定植患者的医护人员中68.9%(250/363)有潜在暴露,其MDRO定植率4.0%(15/379)与无患者接触者3.2%(12/376)无显著差异(p 0.55)。

临床怎么用

  • 非暴发情况下,医护人员肠道MDRO定植率低,常规筛查可能不是必要措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aims to assess the association between patient contact and intestinal carriage of multidrug-resistant organisms (MDRO) by sampling healthcare personnel (HCP) and staff without patient contact. METHODS: For this observational study, we recruited 400 HCP who worked in our 200-bed research hospital and 400 individuals without patient contact between November 2013 and February 2015. Participants submitted two self-collected perirectal swabs and a questionnaire. Swabs were processed for multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci (VRE). Questionnaires explored occupational and personal risk factors for MDRO carriage. RESULTS: Among 800 participants, 94.4% (755/800) submitted at least one swab, and 91.4% (731/800) also submitted questionnaires. Extended spectrum β-lactamase-producing organisms were recovered from 3.4% (26/755) of participants, and only one carbapenemase-producing organism was recovered. No VRE were detected. The potential exposure of 68.9% (250/363) of HCP who reported caring for MDRO-colonized patients did not result in a rate of MDRO carriage among HCP (4.0%; 15/379) significantly higher than that of staff without patient contact (3.2%; 12/376; p 0.55). CONCLUSIONS: This is the largest US study of HCP intestinal MDRO carriage. The low colonization rate is probably reflective of local community background rates, suggesting that HCP intestinal colonization plays a minor role in nosocomial spread of MDROs in a non-outbreak setting. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01952158.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Decker BK, Lau AF, Dekker JP, et al. Healthcare personnel intestinal colonization with multidrug-resistant organisms. Clin Microbiol Infect. 2017. PMID: 28506784. doi:10.1016/j.cmi.2017.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。